BRIEF-Shanghai Interest Medical Instruments Says Entered Second Investment Agreement

Reuters11-29 01:34

Nov 28 (Reuters) - Shanghai INT Medical Instruments 1501.HK:

ENTERED SECOND INVESTMENT AGREEMENT WITH INDIVIDUAL FOR FORMATION OF SHANGHAI INTEREST LIFE
SHANGHAI INTEREST LIFE WILL BE PRIMARILY ENGAGED IN SALE OF COSMETICS, SUPPLEMENTS, AND DISPOSABLE MEDICAL PRODUCTS
REGISTERED CAPITAL OF SHANGHAI INTEREST ASSET MANAGEMENT SHALL BE RMB20.0 MILLION

Further company coverage: 1501.HK

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2487349302?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-29 01:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2487349302","market":"us","top_or_hot":-1,"title":"BRIEF-Shanghai Interest Medical Instruments Says Entered Second Investment Agreement","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Shanghai Interest Medical Instruments Says Entered Second Investment Agreement </title></head><body><p><span>Nov 28 (Reuters)</span><span> - </span>Shanghai INT Medical Instruments <span>1501.HK</span>:</p><ul><li><p>ENTERED SECOND INVESTMENT AGREEMENT WITH INDIVIDUAL FOR FORMATION OF SHANGHAI INTEREST LIFE</p></li><li><p>SHANGHAI INTEREST LIFE WILL BE PRIMARILY ENGAGED IN SALE OF COSMETICS, SUPPLEMENTS, AND DISPOSABLE MEDICAL PRODUCTS</p></li><li><p>REGISTERED CAPITAL OF SHANGHAI INTEREST ASSET MANAGEMENT SHALL BE RMB20.0 MILLION</p></li></ul><p>Further company coverage: <span>1501.HK</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Shanghai Interest Medical Instruments Says Entered Second Investment Agreement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Shanghai Interest Medical Instruments Says Entered Second Investment Agreement\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-29 01:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241128:nFWN3MZ0CK:1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BRIEF-Shanghai Interest Medical Instruments Says Entered Second Investment Agreement Nov 28 (Reuters) - Shanghai INT Medical Instruments 1501.HK:ENTERED SECOND INVESTMENT AGREEMENT WITH INDIVIDUAL FOR...</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241128:nFWN3MZ0CK:1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01501","symbol_name":"瑛泰医疗","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241128:nFWN3MZ0CK:1","article_id":"2487349302","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2487349302","pubTimestamp":1732815251,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Shanghai Interest Medical Instruments Says Entered Second Investment Agreement Nov 28  - Shanghai INT Medical Instruments 1501.HK:ENTERED SECOND INVESTMENT AGREEMENT WITH INDIVIDUAL FOR FORMATION OF SHANGHAI INTEREST LIFESHANGHAI INTEREST LIFE WILL BE PRIMARILY ENGAGED IN SALE OF COSMETICS, SUPPLEMENTS, AND DISPOSABLE MEDICAL PRODUCTSREGISTERED CAPITAL OF SHANGHAI INTEREST ASSET MANAGEMENT SHALL BE RMB20.0 MILLIONFurther company coverage: 1501.HK ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01501":"瑛泰医疗","BK1222":"医疗保健用品"},"translate_title":"简介-上海兴趣医疗器械表示已签订第二份投资协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01501":0.9},"content_text":"BRIEF-Shanghai Interest Medical Instruments Says Entered Second Investment Agreement Nov 28 (Reuters) - Shanghai INT Medical Instruments 1501.HK:ENTERED SECOND INVESTMENT AGREEMENT WITH INDIVIDUAL FOR FORMATION OF SHANGHAI INTEREST LIFESHANGHAI INTEREST LIFE WILL BE PRIMARILY ENGAGED IN SALE OF COSMETICS, SUPPLEMENTS, AND DISPOSABLE MEDICAL PRODUCTSREGISTERED CAPITAL OF SHANGHAI INTEREST ASSET MANAGEMENT SHALL BE RMB20.0 MILLIONFurther company coverage: 1501.HK ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2487349302"}